Alkermes
Presence
Alkermes is one of the...
Alkermes is a company listed under the stock ticker ALKS (US).
Alkermes has a direct presence in 2 countries.
They are in:
- Biotechnology50%
- Pharmaceuticals50%
Executives
View the org chart displaying its 59 main executives
Most searched biographies at Alkermes
- Richard Pops, Chairman of the Board and Chief Executive Officer
- Nancy Snyderman, Director
- Brian McKeon, Director
Popular executive movements at Alkermes
- Nancy Lurker has joined the company as Director (posted on March 8 2024).
- Nancy Wysenski, Lead Director, has left the company (posted on December 11 2023).
Create your alert
to follow the executive moves at Alkermes.
Biotechnology
Alkermes has 2,277 competitors including Eurofins (Luxembourg), Lonza (Switzerland) and Adaptive Phage Therapeutics (United States (USA)).
Popular M&A news in Biotechnology
- Histogen has filed for bankruptcy protection (posted on April 19 2024).
- Bruker has announced the acquisition of NanoString Technologies (posted on April 18 2024).
- Vertex Pharmaceuticals has announced the acquisition of Alpine Immune Sciences (posted on April 16 2024).
Popular contacts in Biotechnology
News
Press releases by Alkermes
- Alkermes plc Reports Second Quarter 2022 Financial Results | Alkermes plc
- Alkermes to Report Second Quarter Financial Results on July 27, 2022 | Alkermes plc
- Alkermes Announces Results of Annual General Meeting of Shareholders | Alkermes plc
- Alkermes to Participate in the Goldman Sachs Healthcare Conference | Alkermes plc
- Alkermes Announces 2022 Alkermes Inspiration Grants® Program to Support Innovative Programs Focused on People Affected by Addiction, Serious Mental Illness or Cancer | Alkermes plc
- Alkermes to Participate in the Jefferies Healthcare Conference | Alkermes plc
- Alkermes Presents ARTISTRY-1 Data at 2022 American Society of Clinical Oncology (ASCO) Annual Meeting | Alkermes plc
- Alkermes Announces Continued Board Refreshment, Including the Appointment of Christopher I. Wright, M.D., Ph.D. to its Board of Directors | Alkermes plc
- Alkermes Announces Four Abstracts Accepted for Presentation at the 2022 American Society of Clinical Oncology (ASCO) Annual Meeting | Alkermes plc
- Our Stories
- View more press releases Close
Social media about Alkermes
- Alkermes on Wikipedia, Google News & Yahoo Finance
- Alkermes on LinkedIn, Twitter & YouTube
Get in Touch
Contact by email its executives including Richard Pops 
